Perrigo Steers Through Transportation Obstacles, Soaring Shipping Costs From COVID-19
Divesting ScarAway Wound-Care Brand Required For US FTC Approval Of HRA Acquisition
Perrigo largely has resolved distribution problems, but shipping freight costs still are much higher than pre-pandemic and it must divest a wound-care brand before US regulators sign off on acquisition of HRA Pharma, says CEO Murray Kessler during J.P. Morgan conference.
